发明名称 |
New nucleic acid encoding mutant factor 7 activating protease, useful for diagnosis, treatment and prevention of coagulation disorders, also related protein and antibodies |
摘要 |
Mutant (A) of the DNA sequence, encoding the protease (FSAP) that activates blood coagulation factor 7 (F7) and single-chain plasminogen activator, has at least one of the base changes G to C at nucleotide (nt) 1177 and G to A at nt 1601. Independent claims are also included for the following: (1) mutant FSAP having at least one of the amino acid exchanges Glu393Gln and/or Gly534Glu; (2) identifying (M1) subjects with genetically related hetero- or homo-zygotic expression of the FSAP mutant by detecting the mutation in genomic DNA or derived mRNA; (3) mono- or poly-clonal antibodies (Ab) directed against FSAP, its proenzyme, cleavage products or mutants; (4) detecting (M2) FSAP, its proenzyme, cleavage products or mutants using Ab; (5) test system for methods (M1) and (M2); (6) preparing (A); (7) purifying, detecting and/or determining FSAP or its proenzyme, using monoclonal Ab or its Fab or F(ab')2 fragments; and (8) detecting (M3) antibodies to FSAP and/or its mutants with one or more amino acid changes.
|
申请公布号 |
DE10052319(A1) |
申请公布日期 |
2002.04.11 |
申请号 |
DE20001052319 |
申请日期 |
2000.10.21 |
申请人 |
AVENTIS BEHRING GMBH |
发明人 |
WEIMER, THOMAS;ROEMISCH, JUERGEN;BECKER, MARGRET;FEUSNER, ANNETTE;NERLICH, CLAUDIA;STOEHR, HANS-ARNOLD |
分类号 |
C12N9/64;C12N15/55;(IPC1-7):C12N9/48;C12Q1/56;A61K39/395 |
主分类号 |
C12N9/64 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|